Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$88.47 – $109.59
52% from low
Exchange
OTC Link
ADRC
NESTLE S.A S/ADR
No one on the platform currently holds NSRGY.
No tracked institution reports a position in NSRGY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-21 | $3.9430 | 2026-05-28 |
| 2025-04-23 | $3.6811 | 2025-05-29 |
| 2024-04-22 | $3.2786 | 2024-05-31 |
| Execution date | Ratio |
|---|---|
| 2008-07-03 | 2.5-for-1 |
No one on the platform has traded NSRGY yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $87.1B | -3.8% | $4.34 | $4.25–$4.45 | 22.9× | 3 |
| 2027 | $89.9B | +3.2% | $4.64 | $4.58–$4.74 | 21.5× | 4 |
| 2028 | $92.8B | +3.3% | $4.96 | $4.81–$5.11 | 20.1× | 2 |
| 2029 | $94.8B | +2.1% | $5.19 | $5.03–$5.34 | 19.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-23 | $2.56 | $2.72 | +6.3% |
| 2026-02-19 | $2.59 | $2.78 | +7.3% |
| 2025-07-24 | $2.63 | $2.48 | -5.7% |
| 2025-02-13 | $2.47 | $2.61 | +5.7% |
| 2024-07-25 | $2.65 | $2.85 | +7.5% |
| 2024-02-22 | $2.93 | $2.61 | -10.9% |
| 2023-07-27 | $2.65 | $2.80 | +5.7% |
| 2023-02-16 | $2.70 |
| $2.67 |
| -1.1% |
| $15.0B |
| — |
| KRYAYKerry Group plc | $96.93 | +1.25% | $15.4B | — |
| LRLCFL'Oréal S.A. | $436.00 | -3.64% | $232.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
Nestlé is reportedly close to an agreement with Platinum Equity to sell roughly 50% of its European water business, according to the Financial Times. The transaction would value the joint venture at approximately €5 billion ($5.7 billion) and could be finalized before Nestlé reports first-half earnings on Thursday. The potential deal is part of CEO Laurent Freixe’s broader effort to streamline Nestlé’s portfolio, improve profitability, and focus resources on the company’s core growth brands. Earlier this year, Nestlé hired Rothschild to explore strategic options for the European water division, including a partnership or partial sale while retaining an ownership stake. The business includes well-known premium water brands such as Perrier, San Pellegrino, and Acqua Panna. A transaction would allow Nestlé to monetize part of the unit while maintaining exposure to the business and potentially benefiting from future operational improvements under Platinum Equity’s involvement. $NSRGY
View on StockTwits ↗Congress Trading Watch New disclosure alert: Rep. Josh Gottheimer reported several stock sales. Recent positions reduced: $BABA Alibaba $NTDOY Nintendo $NSRGY Nestlé $INSM Insmed Each transaction was reported in the $1K–$15K range. Political trades always attract attention because investors are watching how lawmakers adjust their portfolios. Keep this one on your radar. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.
View on StockTwits ↗Nestlé said it will reformulate KitKat across most of Europe beginning in September 2027, making the chocolate bar crispier and adding a subtle hazelnut note while maintaining its cocoa content. The company said the changes are designed to broaden the brand's appeal and are not a response to high cocoa prices, despite rising raw material costs across the chocolate industry in recent years. According to global KitKat brand manager Rouven Lochmuller, the updated recipe will introduce a "third layer" of flavor to create a more complex taste that appeals to both milk and dark chocolate consumers. The U.K. recipe will remain unchanged, as Nestlé believes it already matches local consumer preferences. In the U.S., where Hershey manufactures and markets KitKat, the company has separately announced plans to introduce a creamier recipe in 2027. $NSRGY
View on StockTwits ↗Nestlé said it could lower coffee prices for consumers as green coffee costs continue to decline, with coffee executive Axel Touzet saying the company will factor lower bean prices into future retail pricing decisions. Speaking at Nestlé's headquarters in Vevey, Touzet said any price adjustments will depend on market conditions, inventory levels, and the prices the company previously paid for coffee purchases. Coffee prices surged in 2024 and hit record highs in 2025 after poor weather damaged harvests, but bean prices have generally trended lower this year. As the world's largest coffee company, Nestlé owns brands including Nescafé and Nespresso. Industry experts estimate it takes at least nine months for changes in raw coffee costs to reach consumers because of roasting timelines, inventories, and contract negotiations, meaning retail coffee prices remain elevated despite the recent decline in bean prices. $NSRGY
View on StockTwits ↗$NSRGY not a racing stripe on it, steady upside coming in to stay
View on StockTwits ↗$LKNCY happily invested in an AI driven international coffee company dominating the dinosaur $SBUX in the biggest potential coffee market on earth while rapidly expanding internationally, buying out top tier luxury brands like Blue Bottle from $NSRGY and consciously developing an incredible supply chain with logistics to support their ambitions of becoming a 100 year old company. All this while increasing revenue ~40% a year, expanding to over 34,000 stores and profiting enough to buy back $300,000,000 in shares while doing it! 🤯 what a legendary business. This is the Phinox! Luckin is calculated, in it for the long haul. Complain about share price and relisting but this is not the company’s focus yet. Luckin is still in the growth phase, they don’t need a cash influx, the company is run so well it’s profitable while expanding. Store count will surpass Starbucks in 2027, revenue surpasses the Bux in 2030, that’s only 4 years away guys! Nothing can stop us, nothing can catch us.
View on StockTwits ↗Nestlé and Danone are facing renewed scrutiny over how they handled the recall of contaminated infant formula, following investigations by public broadcasters in France, Belgium, and Switzerland. The reports allege that Nestlé delayed notifying European authorities about the presence of cereulide, a toxin that can cause vomiting and diarrhea and poses heightened risks for infants. The contamination was linked to an ingredient supplied by China’s CABIO Biotech and used in products from multiple manufacturers, including Nestlé, Danone, and Lactalis. According to the investigation, trace levels of the toxin were detected as early as November, but public recalls were only initiated in January, raising questions about whether affected products remained in distribution channels or households without timely warnings. The reports also suggested that some withdrawals may have been carried out quietly in certain markets before official recalls were issued. $NSRGY $DANOY
View on StockTwits ↗Nestle Surpasses Q1 Expectations As Coffee And Food Sales Rise $NSRGY https://talkmarkets.com/article/nestle-surpasses-q1-expectations-as-coffee-and-food-sales-rise-1776929743
View on StockTwits ↗$BB shoulda used BB - $NSRGY Thieves steal truck with over 400K of KitKat bars in Europe https://share.google/9vBf59TUR8ygR8BOI
View on StockTwits ↗$NSRGY $DIA $SPY $QQQ $VOO "12 tons of KitKat bars stolen in chocolaty heist in Europe, Nestle says" This must have made for an awkward fencing. I can just see the fence's confusion: 'When you said "I can steal 12 tons of bars", we thought gold was implied.' https://www.cbsnews.com/news/nestle-kitkat-shipment-heist-stolen-europe/
View on StockTwits ↗Canaccord just upgraded Seres Therapeutics with a $22 price target. With the stock currently at $8.63, that’s a potential upside of roughly +155% (Ser 155 🙃) But the upgrade isn’t the only thing catching attention. With Seres’ assets, its strategic positioning, and growing interest from larger players in the microbiome space, a buyout scenario is becoming increasingly realistic. The valuation gap is huge, and Seres could be a fast, strategic acquisition for any pharma looking to strengthen its pipeline. This upgrade might be the first real signal. $MCRB $MRK $NSRGY #Canaccord #BuyoutPotential
View on StockTwits ↗$LKNCY $NSRGY https://finance.yahoo.com/news/nestl-refocuses-coffee-portfolio-blue-190854697.html
View on StockTwits ↗$AMFN has alot of upcoming catalysts. 60% share cancelation is the 1st that unlocks 10 others. Ranging from form 10, to ticker change. Scroll down and you'll some some good dd $TCEHY $SSNLF $NSRGY
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.